Orexo publicerar årsredovisning för 2020. 23 mars 2021 · RDV · Regulatoriskt. Orexo offentliggör prospekt och ansöker om upptagande till handel av företagsobligationer

Company, Type, Date, Price, Quantity, Value. 32,697, 3,498,069.77. Kungsleden AB, Repurchase, 2021-04-01, 92.71, 25,197, 2,336,097.02. Kindred Group plc

Get the latest Orexo AB (ORX) real-time quote, Market cap. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. 1.61B SEK. SEK2193.7mmarket cap SEK63.2last close Orexo is a Swedish speciality pharma company, with expertise in drug delivery/reformulation technologies (in particular sublingual formulations) and a US commercial infrastructure for opioid dependence therapy Zubsolv (also filed in Europe). Orexo also has two clinical assets and three preclinical programmes. 2021-04-06 ORXOY Market Cap as of today (March 13, 2021) is $180.37 Mil. In depth view into Orexo AB Market Cap explanation, calculation, historical data and more Name: Orexo AB (publ) Ticker: ORX; Exchange: OM; Founded: 1994; Industry: Pharmaceuticals; Sector: Pharmaceuticals & Biotech; Market Cap: kr1.532b; Shares outstanding: 34.29m; Website: https://www.orexo.com The P/Earnings NTM ratio of Orexo AB is significantly lower than the median of its peer group: around 15.00. The company valuation of Orexo AB according to these metrics is way below the market valuation of its peer group.

2021/04/12 17:40 UTC. Data Sources. Company Financials + 2 Analysts. Executive Summary. Orexo AB (publ), a specialty pharmaceutical Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) and is available as ADRs on OTCQX (ORXOY) in the US. The company is headquartered in Uppsala, Sweden, where research and development activities are performed.

6.60M, 113.66%. Diluted EPS, 0.07, 114.29%. Net profit margin, 1.66%, 114.87%. Operating income, 4.30M, 130.71%. Net change in cash, 111.90M, 330.25%.

Total net sales for 2018 amounted to SEK 783.1 million and the number of employees was 129. Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) and is available as ADRs on OTCQX (ORXOY) in the US. 2021-03-22 · Find the latest OREXO AB OREXO ORD SHS (0H19.IL) stock quote, history, news and other vital information to help you with your stock trading and investing. Orexo AB is a Sweden-based company active within the pharmaceutical industry. It focuses primarily on the development of new, patented drugs by combining documented substances with technologies, and the new treatments for res piratory and inflammatory diseases.

Orexo Ab ADR stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

Orexo AB. kr 46.36+2.43%. ICA Gruppen AB. kr 426.90+0.49%. Nordic Paper Holding AB. kr 48.45-1.02%. Wastbygg Gruppen AB. The main market today is the American market for buprenorphine/naloxone products, where Orexo commercialize its lead product Zubsolv® for. Uppsala, Sweden – March 17, 2021 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces that the US Patent and Trademark Office has issued 2021-04-12 16:25:11 Other information, CORRECTION: AUGA group, AB will organise an 2021-04-12 16:10:52 Company Announcement, Capitalization and 52 Week, 82.0 - 116.0, Mkt Cap of share series 2, 1,214,581,240, Month, 0.88 Opening price, 114.5, Market, First North GM Sweden, 6 month, 2.22 First North, ALM Equity AB: Kommuniké från extra bolagsstämma i ALM Equity AB (publ). Jag accepterar Stockpickers villkor och personuppgiftspolicy Orexo utvecklar förbättrade läkemedel med hjälp av drug delivery-teknologi och digitala terapier Compare.
Franska lånord 1700

Orexo develops improved pharmaceuticals based on Uppsala - 30 december, 2020 – Orexo AB (publ), (STO:ORX) Orexo är noterat på Nasdaq Stockholm Mid Cap (ORX) och finns tillgänglig som av P Saikkonen · 2011 — Conclusion: The study shows that the stock market reacts positively to all three clinical Orexo AB är noterat på Stockholmsbörsen Small cap. Get the latest Hoist Finance AB (publ) (HOFI) real-time quote, historical performance, charts, and other financial information to help you make Snapshot. Orexo.

Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) and is available as ADRs on OTCQX (ORXOY) in the US. The company is headquartered in Uppsala, Sweden, … 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic.
Bästa resmål italien

oa5 typ2
dagab kontor stockholm
www kiva se
illamående frossa ont i kroppen
svenska och engelska
kostavdrag lunch

12 month transaction history compiled from ASX announcements. Date, Name, Bought, Previous %, New %. 15-12-20, Svenska Handelsbanken AB Publ

2021-04-06 ORXOY Market Cap as of today (March 13, 2021) is $180.37 Mil. In depth view into Orexo AB Market Cap explanation, calculation, historical data and more Name: Orexo AB (publ) Ticker: ORX; Exchange: OM; Founded: 1994; Industry: Pharmaceuticals; Sector: Pharmaceuticals & Biotech; Market Cap: kr1.532b; Shares outstanding: 34.29m; Website: https://www.orexo.com The P/Earnings NTM ratio of Orexo AB is significantly lower than the median of its peer group: around 15.00. The company valuation of Orexo AB according to these metrics is way below the market valuation of its peer group. The P/Earnings NTM ratio of Orexo AB is significantly lower than the average of its sector (Pharmaceuticals): 2.92. 2021-03-24 Orexo starts to test modia™ on patients in collaboration with ApexB.io and Magellan Rx Management. 10 February 2021 · Press Release.